You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Trastuzumab

Showing 1 - 25 of 1,441
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

Recruiting
  • Metastatic Salivary Gland Carcinoma
  • +4 more
  • New York, New York
    Memorial Sloane Kettering Cancer Center
Jan 11, 2023

Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus Trastuzumab

Active, not recruiting
  • Breast Cancer
  • Pyrotinib Plus Trastuzumab
  • Pertuzumab Plus Trastuzumab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 5, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Duarte

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Copper Cu 64-DOTA-Trastuzumab
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,

Completed
Has Results
  • HER2 Positive Breast Carcinoma
  • +6 more
  • Palo Alto, California
    Stanford University, School of Medicine
Sep 22, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +5 more
  • Trastuzumab
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 31, 2023

Safety and Efficacy of Trastuzumab BS

Not yet recruiting
  • Gastric Cancer
  • TRASTUZUMAB BS
  • (no location specified)
Dec 19, 2022

Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Necitumumab
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jan 5, 2023

Early-stage Breast Cancer, HER2-positive Breast Cancer, Adjuvant Treatment After Trastuzumab Trial in Guangzhou (Trastuzumab and

Recruiting
  • Early-stage Breast Cancer
  • +4 more
  • Trastuzumab and nelatinib
  • Trastuzumab and Parstuzumab
  • Guangzhou, China
    Sun Yat-sen University Sun Yat-sen Memorial Hospital
Mar 12, 2023

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Los Angeles, California
  • +4 more
Jul 19, 2022

Breast Cancer, Tumor Metastasis Trial in Houston (Trastuzumab, RAD001)

Completed
Has Results
  • Breast Cancer
  • Neoplasm Metastasis
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 30, 2022

Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)

Not yet recruiting
  • Breast Cancer
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Dec 2, 2022

Breast Cancer Trial (Pyrotinib, Trastuzumab, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Apr 22, 2023

Breast Tumor Female Trial (Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy)

Not yet recruiting
  • Breast Neoplasm Female
  • Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy
  • (no location specified)
Oct 17, 2022

HER2-positive Breast Cancer Trial (Paclitaxel + Trastuzumab, Trastuzumab)

Not yet recruiting
  • HER2-positive Breast Cancer
  • Paclitaxel + Trastuzumab
  • Trastuzumab
  • (no location specified)
May 24, 2022

Breast Tumors, Malignant Tumor of the Breast Trial in Multiple Locations (Trastuzumab, Pertuzumab, Vinorelbine, Paclitaxel,

Terminated
  • Breast Neoplasms
  • Malignant Tumor of the Breast
  • Trastuzumab
  • +2 more
  • Multiple Locations, Texas
    19 Sites
Nov 29, 2022

HER2-positive Breast Cancer, Metastatic Breast Cancer Trial in Shanghai (Trastuzumab plus chemo, Trastuzumab in combination with

Recruiting
  • HER2-positive Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab plus chemotherapy
  • Trastuzumab in combination with pyrotinib plus chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 20, 2022

Breast Cancer Trial in Yantai (pyrotinib combined with trastuzumab, dalpiciclib and letrozole)

Recruiting
  • Breast Cancer
  • pyrotinib combined with trastuzumab, dalpiciclib and letrozole
  • Yantai, Shandong, China
    Yantai Yuhuangding Hospital
Mar 23, 2023

Breast Cancer Trial in Amsterdam (Monalizumab, Trastuzumab)

Active, not recruiting
  • Breast Cancer
  • Monalizumab
  • Trastuzumab
  • Amsterdam, Netherlands
    NKI-AVL
Jul 15, 2022

HER2-positive Advanced Gastric Cancer Trial (trastuzumab, bevacizumab with paclitaxel (triple combination))

Not yet recruiting
  • HER2-positive Advanced Gastric Cancer
  • trastuzumab, bevacizumab with paclitaxel (triple combination)
  • (no location specified)
Dec 6, 2022

Breast Cancer Trial in Shanghai (Dalpiciclib, Fulvestrant, Pertuzumab)

Active, not recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 10, 2022

Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Changchun (Trastuzumab for injection, Herceptin)

Completed
  • Metastatic Breast Cancer
  • Metastatic Gastric Cancer
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Mar 1, 2023

Breast Cancer Trial in Shenyang (Pyrotinib maleate, dalpiciclib, Trastuzumab, letrozole)

Recruiting
  • Breast Cancer
  • Pyrotinib maleate, dalpiciclib, Trastuzumab, letrozole
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Sep 12, 2022

Trastuzumab(Henlius®) Combined With Pertuzumab(Perjeta®) and

Recruiting
  • HER2-positive Metastatic Breast Cancer
  • +2 more
  • trastuzumab(Henlius®) combined with Pertuzumab(Perjeta®) and Chemotherapy
  • Beijing, Beijing, China
    Ruyan Zhang
Dec 27, 2021

Esophagogastric Adenocarcinoma Trial (Pembrolizumab, Trastuzumab, FLOT)

Not yet recruiting
  • Esophagogastric Adenocarcinoma
  • (no location specified)
Aug 17, 2022

Metastatic HER2-Positive Breast Cancer Trial in United States (Gemcitabine, Trastuzumab, Pertuzumab)

Active, not recruiting
  • Metastatic HER2-Positive Breast Cancer
  • Hartford, Connecticut
  • +4 more
Dec 1, 2022